Phase 4- The role of montelukast on perennial rhinitis and associated sleep disturbance and daytime somnolence

Trial Profile

Phase 4- The role of montelukast on perennial rhinitis and associated sleep disturbance and daytime somnolence

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Nov 2014

At a glance

  • Drugs Montelukast (Primary)
  • Indications Perennial allergic rhinitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Nov 2008 Secondary endpoint 'Symptom score' has been met.
    • 01 Apr 2008 Primary endpoint 'Epworth Sleepiness Scale' has been met.
    • 01 Apr 2008 Secondary endpoint 'Rhinoconjunctivitis Quality of Life Questionnaire' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top